Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: A survey of mothers and adolescents

Highlights • We did a representative assessment of HPV vaccine acceptability in Hong Kong. • We found that while acceptability was moderate, the actual uptake was markedly lower. • Female adolescent HPV vaccine acceptability increased from 2008 to 2012. • The willingness to pay of HPV vaccination wa...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2013-12, Vol.32 (1), p.78-84
Main Authors: Choi, Horace C.W, Leung, Gabriel M, Woo, Pauline P.S, Jit, Mark, Wu, Joseph T
Format: Article
Language:English
Subjects:
Adolescent
Adolescents
Adult
Age Factors
Aged
Allergy and Immunology
Applied microbiology
Attitudes
Biological and medical sciences
Cervical cancer
Female
Females
Fundamental and applied biological sciences. Psychology
Health expenditures
Health Knowledge, Attitudes, Practice
Health Surveys
Hong Kong
Hong Kong - epidemiology
HPV vaccines
Human papillomavirus
Humans
Immunization
Medical sciences
Microbiology
Middle Aged
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines - immunology
Patient Acceptance of Health Care - statistics & numerical data
Risk Factors
Surveys and Questionnaires
Tumors
Vaccination - statistics & numerical data
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • We did a representative assessment of HPV vaccine acceptability in Hong Kong. • We found that while acceptability was moderate, the actual uptake was markedly lower. • Female adolescent HPV vaccine acceptability increased from 2008 to 2012. • The willingness to pay of HPV vaccination was largely lower than the market price. • Cost of vaccination was a barrier against HPV vaccine acceptability.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.10.068